13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001213900-26-016236
Total Value
$1.55B
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | TERN | 5,346,928 | $216.0M | 13.96% |
| 2 | Cidara Therapeutics, Inc. | 171757206 | 956,670 | $211.3M | 13.66% |
| 3 | Praxis Precision Medicines | PRAX | 328,895 | $96.9M | 6.27% |
| 4 | Cogent Biosciences Inc | COGT | 2,398,993 | $85.2M | 5.51% |
| 5 | Trevi Therapeutics Inc | TRVI | 5,094,668 | $63.8M | 4.12% |
| 6 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $57.8M | 3.74% |
| 7 | Compass Therapeutics Inc | CMPX | 9,545,466 | $51.3M | 3.31% |
| 8 | Dyne Therapeutics Inc | DYN | 2,614,960 | $51.1M | 3.31% |
| 9 | Abivax SA - ADR | AAVXF | 359,305 | $48.5M | 3.13% |
| 10 | DBV Technologies SA | DBVTF | 2,461,626 | $47.2M | 3.05% |
| 11 | SAB Biotherapeutics Inc | SABSW | 11,420,000 | $42.7M | 2.76% |
| 12 | Soleno Therapeutics Inc | SLNO | 894,909 | $41.4M | 2.68% |
| 13 | Bright Minds Biosciences Inc | DRUG | 501,617 | $39.1M | 2.53% |
| 14 | Sinovac Biotech Ltd. | SVA | 5,903,000 | $38.2M | 2.47% |
| 15 | Geron Corp | GERN | 27,225,292 | $35.9M | 2.32% |
| 16 | Erasca Inc | ERAS | 9,273,428 | $34.5M | 2.23% |
| 17 | Zenas Biopharma Inc | ZBIO | 853,495 | $31.0M | 2.00% |
| 18 | Viridian Therapeutics Inc | VRDN | 982,576 | $30.6M | 1.98% |
| 19 | Aclaris Therapeutics, Inc. | ACRS | 8,888,888 | $26.8M | 1.73% |
| 20 | CAMP4 Therapeutics Inc | CAMP | 4,246,568 | $26.0M | 1.68% |
| 21 | Tango Therapeutics Inc | TNGX | 2,154,780 | $19.1M | 1.23% |
| 22 | Alto Neuroscience Inc | ANRO | 1,035,551 | $18.4M | 1.19% |
| 23 | LB Pharmaceuticals Inc | LBRX | 800,000 | $17.8M | 1.15% |
| 24 | Minerva Neurosciences Inc | NERV | 4,322,747 | $17.4M | 1.12% |
| 25 | Oric Pharmaceuticals Inc | ORIC | 2,118,384 | $17.3M | 1.12% |
| 26 | Corvus Pharmaceuticals Holdings | CRVS | 2,234,566 | $17.2M | 1.11% |
| 27 | Olema Pharmaceuticals Inc | OLMA | 671,843 | $16.8M | 1.09% |
| 28 | Pepgen Inc | PEPG | 2,325,000 | $15.1M | 0.98% |
| 29 | Design Therapeutics Inc | DSGN | 1,612,903 | $15.1M | 0.98% |
| 30 | Dianthus Therapeutics Inc | DNTH | 353,998 | $14.6M | 0.94% |
| 31 | Moonlake Immunotherapeutics | MLTX | 1,000,000 | $13.2M | 0.85% |
| 32 | Cytomx Therapeutics Inc | CTMX | 2,884,615 | $12.3M | 0.79% |
| 33 | Unicycive Therapeutics | UNCY | 1,789,916 | $10.3M | 0.67% |
| 34 | Eupraxia Pharmaceuticals Inc | EPRX | 1,350,000 | $10.2M | 0.66% |
| 35 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $9.7M | 0.63% |
| 36 | Verastem Inc | VSTM | 1,106,524 | $8.5M | 0.55% |
| 37 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $6.7M | 0.43% |
| 38 | Monopar Therapeutics Inc | MNPR | 90,500 | $5.9M | 0.38% |
| 39 | Surrozen Inc | SRZNW | 260,000 | $5.9M | 0.38% |
| 40 | Palisade Bio Inc | PALI | 2,293,578 | $5.4M | 0.35% |
| 41 | Sera Prognostics Inc | SERA | 1,650,440 | $4.9M | 0.31% |
| 42 | Instil Bio Inc | TIL | 292,743 | $3.2M | 0.21% |
| 43 | Pasithea Therapeutics Corp | KTTAW | 2,100,000 | $2.7M | 0.18% |
| 44 | Tenax Therapeutics Inc | TENX | 208,333 | $2.5M | 0.16% |
| 45 | EnGene Holdings Inc | ENGNW | 285,046 | $843,736 | 0.05% |
| 46 | Bolt Therapeutics Inc | BOLT | 72,414 | $395,960 | 0.03% |
| 47 | Precision Biosciences Inc | DTIL | 4,675 | $19,449 | 0.00% |